Skip to main content
5N Plus Inc. logo

5N Plus Inc. — Investor Relations & Filings

Ticker · VNP ISIN · US33833X2009 LEI · 5493005GU1NFX4YB2S73 TSX Manufacturing
Open in API
Filings indexed 345 across all filing types
Latest filing 2021-01-12 Regulatory Filings
Country CA Canada
Listing TSX VNP

About 5N Plus Inc.

https://www.5nplus.com

5N Plus is a leading global producer of specialty semiconductors and performance materials. The company utilizes proprietary technologies to develop and manufacture ultra-pure materials, high-purity metals, compounds, alloys, and specialized chemicals, including Active Pharmaceutical Ingredients (APIs). These critical materials form core components for advanced applications across several key markets: Terrestrial Renewable Energy (e.g., Cadmium Telluride for solar cells), Space Solar Power, Imaging and Sensing (e.g., Cadmium Zinc Telluride), Health and Pharma, and Technical Materials. The company operates with an integrated approach, featuring closed-loop recycling facilities, emphasizing sustainable development and the circular economy.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release dated January 12, 2021, announcing that 5N Plus has acquired a stake in Microbion and secured drug substance manufacturing rights. It discusses the strategic relationship, clinical development programs, financing, and forward-looking statements. There are no financial statements, regulatory filings, or detailed financial performance data included. The content is focused on a corporate transaction and partnership announcement rather than a financial report or regulatory filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Capital/Financing Update. It is not a merger or acquisition filing in the formal sense (no merger proxy or tender offer forms). The document is best classified as a Regulatory Filing (RNS) because it is a general corporate announcement that does not fit other specific categories.
2021-01-12 English
News release - French.pdf
Regulatory Filings Classification · 95% confidence The document is a press release dated January 12, 2021, announcing a strategic agreement between 5N Plus and Microbion Corporation related to the development of a new category of antibiotics and antibiofilm agents. It discusses business initiatives, investments, and future growth plans but does not contain any financial statements, detailed financial performance data, or regulatory filing references. There is no indication that this is an earnings release, annual or interim report, or any other formal regulatory filing. The content is typical of a corporate press release announcing a business development or partnership. Therefore, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2021-01-12 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release dated January 12, 2021, announcing a strategic agreement and business expansion related to pharmaceutical ingredients. It contains no financial statements, no detailed financial data, no regulatory certifications, or voting results. It is a corporate announcement about business development and strategic partnership, not a financial report or regulatory filing. The document length is 7166 characters, which is sufficient for a press release but does not contain the depth or structure of an annual or interim report. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is clearly a Capital/Financing Update as it announces a strategic agreement, equity stake acquisition, and business expansion related to capital and financing activities.
2021-01-12 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release dated November 12, 2020, announcing that 5N Plus has secured multi-year semiconductor supply contracts in the renewable energy sector. It contains no financial statements, detailed financial analysis, or regulatory form references. It is a corporate announcement about business development and contract wins, not a financial report or regulatory filing. The document is longer than 5,000 characters but is clearly a press release about a business update. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous corporate announcements that do not fit other categories.
2020-11-12 English
News release - French.pdf
Capital/Financing Update Classification · 85% confidence The document is a press release dated November 12, 2020, announcing that 5N Plus has signed significant supply contracts for semiconductor materials in the renewable energy sector. It discusses business developments, partnerships, and future outlook but does not contain financial statements, detailed financial performance data, or regulatory filing references. It is not an earnings release, annual or interim report, or any regulatory filing. The content is a corporate announcement about new contracts and business activities, typical of a Capital/Financing Update or general corporate news. Since it relates to new supply contracts and business development rather than financing or capital structure changes, the best fit is Capital/Financing Update (CAP). The document length is sufficient and contains substantive information, not just a brief announcement or report publication notice.
2020-11-12 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109F2 Certification of Interim Filings by the CEO of 5N Plus Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2020. The content is primarily an officer certification regarding the interim filings, controls, and procedures, without containing actual financial statements or substantive financial data. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3266 characters, which is relatively short and consistent with a certification letter rather than a full interim report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2020-11-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.